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Costimulatory signals provided by T cells are required for B cells to produce specific antibody
to T-dependent antigen. We have investigated the suitability of using the CD40 culture system
for the proliferation and differentiation of Ag-specific human B cells using cytomegalovirus
(CMV) or tetanus toxoid (TT) as antigen. We modified the CD40 culture system (CD32-
transfected L cells, anti-CD40, and IL-4) by applying a sequential cytokine stimulation and
compared total B-cell cultures with antigen-specific B cells preselected by panning. The
detection of specific antibody became possible when antigen-selected B cells were cultured for
7 days in the CD40 system to induce clonal expansion, followed by the addition of IL-2 and IL-
l0 for an additional 7 days to induce plasma-cell differentiation. We conclude that our intial
inability to detect specific antibody in the CD40 system is due to overgrowth of nonspecific B-
cell clones and that selection of antigen-specific B cells by panning overcomes this problem.
Induction of antigen-specific antibody production was found to be optimal when the initial
contact with antigen during panning was limited to between to 24 hours.
Keywords." Specific antibody, anti-CD40, human B lymphocytes, cytomegalovirus (CMV)
INTRODUCTION
Antibody responses to thymus-dependent antigens are
mediated by cytokines and B-cell-surface receptor-
ligand interactions provided by T helper cells. One of
the important T-cell surface ligands is CD40L that
interacts with CD40 on B cells and that is transiently
expressed on activated T cells during the immune
response (Banchereau et al., 1991; Hollenbaugh et al.,
1992). Ligation of CD40 on B cells has a wide range
of effects, that is, together with IL-4, it gives a
*Corresponding author.
costimulatory signal for proliferation (Clark et al.,
1988; Banchereau et al., 1991; Rousset et al., 1995)
and heavy-chain switching (Gascan et al., 1991),
whereas such ligation together with IL-2, IL-10, or
IL-15 induces antibody secretion (Rousset et al.,
1992, 1995; Armitage et al., 1993). Furthermore,
CD40 and B-cell antigen receptor (BCR) dual trigger-
ing of resting B lymphocytes turns on a partial
germinal center phenotype (Galibert et al., 1996A),
and CD40 ligation is thought to be essential in the
rescue of germinal center B cells from apoptosis after
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somatic mutation in the germinal center (Liu et al.,
1992). In vitro, the continued stimulation of germinal
center B cells by anti-CD40 in the presence of IL-2
and IL-10 promotes the generation of CD38-CD20
memory B cells, whereas removal of the anti-CD40
signal induces plasma cell differentiation (Arpin et
al., 1995).
The CD40 culture system described by Banchereau
et al. (1991), in which highly purified B cells can be
maintained for long periods through cross-linking
surface CD40 in the presence of IL-4, opened up new
possibilities for the in vitro study of human B
lymphocytes. However, there have been conflicting
reports about the suitability of this system for antigen-
driven B-cell expansion and specific antibody produc-
tion in vitro. Nonoyama et al. (1993) report that the
continued presence of antigen, anti-CD40, and IL-10
enabled the induction of phage-specific antibody
whereas Callard et al. (1995) found that CD40 cross-
linking in the presence of IL-2-inhibited specific
(influenza virus) antibody production by purified
human B cells.
We show in the present report that the "standard"
CD40 system fails to sustain specific antibody-
secreting B cells, an effect that might be due to
overgrowth of nonspecific B-cell clones. However,
preselection of specific B cells before placing in
culture with CD32/L cells, anti-CD40, and IL-4 to
induce clonal expansion, followed by plasma cell
induction with IL-2 and IL-10, enables the detection
of specific antibody. In addition, prolonged contact
with antigen during stimulation with anti-CD40 and
IL-4 appears to inhibit the subsequent formation of
antibody-producing plasma cells.
RESULTS
Antibody Production in FACS-Sorted Splenic B
Cells from a CMV-Positive Donor Cultured in
the CD40 System
During preliminary experiments to examine the
response of memory B cells in the CD40 culture
system, we used B cells from individuals known to
have been exposed to various antigens such as tetanus
toxoid (vaccination) or cytomegalovirus (natural or
iatrogenic infection). FACS-sorted splenic B cells
(CD20+; > 98% pure) were cultured with CD32/L
cells, anti-CD40 (Mab89), and IL-4. At days 7 and 14,
the medium was refreshed and IL10/IL-2 were added
to induce plasma cell differentiation. The majority of
cells showed good proliferation that was maintained
for at least 4 weeks, however, we were only able to
detect a very low level of CMV-specific antibody
(one anti-CMV antibody-producing culture out of 144
in three separately performed experiments using the
same donor material). In contrast, pokeweed mitogen
(PWM) stimulation of splenic mononuclear cells
(MNC) from similar donors latently infected with
CMV showed lgG anti-CMV antibody in 2/3 cases (at
least one positive well per 150,000 cells compared to
one per 5,500,000 cells in the CD40 cultures). A
similar pattern was found for the IgG anti-tetanus
antibody (results not shown). These last results
suggest that the frequency of specific B cells is not the
limiting factor and that specific antibody may be
undetectable due to preferential stimulation of non-
specific B clones or of a particular splenic B-cell
compartment.
Addition of CMV Antigen to CD40 Cultured
Splenic B Cells
Firstly, we asked if the addition of CMV antigen to
the cultures could provide a stimulating effect by
inducing a higher frequency of detectable antigen-
specific antibody. Highly purified CD20 splenic B
cells from CMV-positive donors were placed into
culture with CD32/L cells, anti-CD40, IL-4, and
antigen. Antigen was in the form of (1) a cell lysate of
CMV LA-infected fibroblasts, (2) the recombinant
CMV protein: pp65, or (3) as immune complexes
(consisting of CMV recombinant proteins, r.pp65,
complexed with mouse IgG1 anti-pp65, Mab C 10; or
m.IgG2a anti-pp65, C12). Vigorous B-cell prolifera-
tion was observed at day 4 in all wells where anti-
CD40 and IL-4 were present and the presence of
antigen in any form did not increase this. See Figure
1. One exception, however, was in the case of theAG-SPECIFIC ANTIBODY IN THE CD40 SYSTEM 263
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FIGURE Addition of antigen in the form of soluble CMV proteins or as immune complex does not increase the proliferation at day 4
of anti-CD40/IL-4 cultured B cells. After 7 days, culture was continued by adding IL-2/IL-10 to induce plasma cell differentiation, however,
no CMV-specific antibody could be detected. Antigen was added in the form of (a) cell lysate of CMV LA-infected fibroblasts, (b)
recombinant CMV protein; r.pp65, or (c) immune complexes as described in Materials and Methods. Proliferation (3H-Thymidine uptake)
was determined after 4 days and expressed as the mean dps +SD of triplicate cultures. L CD32 transfected L cells; B B lymphocytes;
IL-4 interleukin-4; 40 anti-CD40; CMV LA lysate of CMV-infected fibroblasts; Mab. 89. C12 m.IgG2a anti-pp65; C10 m.IgG1
anti-pp65; pp65 recombinant pp65.
CMV cell lysate (CMV LA) that appeared to have an
additional mitogenic effect with a large increase in the
size and number of clones per well observed micro-
scopically at day 7 (data not shown). The data in
Figure illustrate the strong B-cell proliferation
induced in all anti-CD40/IL-4 cultures either with or
without antigen. After a further 7 days culture with
IL-10/IL-2, IgM (250-350 ng/ml) and IgG (20-50 ng/
ml) were detected in all wells, but CMV-specific
antibody could not be detected at any time.
Dual Triggering by Anti-CD40 and Ag to
Selectively Activate the Antigen-Specific B Cells
Next we asked if we could selectively activate the
antigen-specific B cells by dual triggering of CD40
and the BCR but without the additional stimulation of
cytokines. B-cell cultures were set up with anti-CD40,
immobilized on CD32/L cells together with antigen
(in the form of soluble protein or immune complexes
as before), but without IL-4 for the first 4 days. In
separate experiments, we had found that CD40/Ag-
stimulated B cells showed some limited proliferation
for up to 4 days in the absence of IL-4 and could be
"rescued" for continued growth by transfer to fresh
CD40/CD32/L cultures with IL-4. After 5 days (day
9), IL-10/IL-2 were added to induce plasma cell
differentiation and medium and cytokines were
refreshed again at 7-day intervals.
By restricting the signals to anti-CD40 and antigen
for the first 4 days, it was hoped to preferentially
activate only those B cells specific for one of the
CMV proteins. Total IgM and IgG in cultures where
signals were restricted to .anti-CD40 and CMV
antigens was considerably less than in control wells
(CD40/IL-4), which would be expected with a264 GRZEGORZ SKIBINSKI et al.
selective stimulation of specific B cells (Figure 2).
However, again CMV-specific antibody could not be
detected. This experiment shows that although 4 days
of CD40/Ag stimulation permits survival of (a subset
of) B cells without IL-4, the subsequent Ig production
by the rescued B cells does not include any detectable
specific antibody, suggesting that selective stimula-
tion and expansion of Ag-specific B cells did not
occur.
Culture of Antigen-Selected B Cells in CD40
System. Panning of Peripheral Blood B Cells
from Patients with an Active CMV Infection
In order to increase the starting number of antigen-
specific cells, peripheral blood from donors who had
recently experienced an active secondary CMV
infection (high IgG anti-CMV antibody levels in
serum) was chosen as source of specific B cells. In
addition, a selection procedure was carried out by
panning (Steenbakkers et al., 1994) CMV-specific B
cells over CMV LA or recombinant pp65 (r.pp65) or
r.gH. Similarly, CMV-specific B cells from a CMV
spleen were selected by panning. The selected B cells
were cultured as described and supematant was
removed for analysis at 7-day intervals and replaced
by fresh culture medium and the relevant cytokines.
On microscopic examination, small clusters of B cells
were observed in most culture wells during the first 7
days. However, the compact clusters characteristic of
anti-CD40-stimulated B cells were considerably
smaller than seen in nonselected B-cell cultures. After
the addition of IL-10 and IL-2, increasing numbers of
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FIGURE 2 Antibody production after dual triggering of CMV-specific B cells with antigen and anti-CD40. Highly purified human B cells
were stimulated 4 days with anti-CD40 and CMV antigens but without IL-4. Antigen was in the form of soluble protein or immune
complexes as in Fig. 1. The surviving B cells were rescued by transfer to fresh anti-CD40 cultures containing IL-4. After 5 days, culture
was continued in IL-10/IL-2. This figure shows total IgM and IgG production in the culture supernatant at day 14. Anti-CMV antibody was
not detectable in any of these cultures. The data shown represent the mean _+ SD of triplicate cultures. L CD32-transfected L cells; B
B lymphocytes; IL-4 interleukin-4; 40 anti-CD40; CMV LA lysate of CMV-infected fibroblasts; Mab. 89. C12 m.IgG2a anti-pp65;
C10 m.IgG1 anti-pp65; pp65 recombinant pp65.AG-SPECIFIC ANTIBODY IN THE CD40 SYSTEM 265
TABLE The Number of Cultures Containing Total IgM or IgG or Specific Antibody at Day 14 in CD40-Cultured Peripheral Blood or
Splenic B Cells after Panning
B cells Antigen IgG + IgM Ag-specific Ag-specific/
(panning) positive/wells seeded Ig (no. wells) total seeded (%)
1. FACS isolated spleen None 48/48 0 0
1. FACS isolated spleen CMVLA 8/8 12.5
2. PB/MNC CMVLA 33/48 13 27.1
2. PB/MNC CMV r.pp65 16/40 2.5
2. PB/MNC CMV r.gH 5/64 2 3.1
2. PB/MNC TT 5/6 3 50
aCD20 sorted splenic B cells were panned or placed directly in culture as described. Peripheral blood mononuclear cells (PB/MNC) were
panned over antigen as indicated.
bAntigen: CMV LA lysate of CMV-infected fibroblasts; CMV r.pp65 recombinant CMV glycoprotein; and CMV r.gH recombinant
CMV glycoprotein.
free lying plasma cells were observed, as is typical in
the nonselected B-cell cultures.
Optimal Ig production was found in the culture
supernatants harvested between days 14 and 17 with
CMV-specific antibody only being detectable from
day 14 onwards. This suggests that the specific
antibody producers have first undergone a pro-
liferative phase under influence of anti-CD40 and IL-
4 before differentiating to antibody-secreting B cells
in the presence of IL-10/IL-2. That nearly all wells
show good Ig production proves the presence of
functional B cells (Table I).
The data in Table 1 show that CMV-specific B cells
can be selected by panning and that the frequency of
specific-antibody-producing wells depends on the
nature of the antigen used for selection. The panning
experiments with the highest number of wells con-
taining antibody specific for CMV were those where
CMV LA was used to select B cells, which is to be
expected since the CMV LA lysate contains a wide
variety of CMV antigens (see Table 1). In a
comparable experiment, tetanus-specific B cells were
selected by panning over TT and cultured as
described for CMV-specific B cells. Here, antigen-
specific clones were obtained in 50% of the culture
wells. (Table 1). These results suggest a higher
precursor frequency for tetanus-toxoid-specific B
cells than for CMV.
It appears from this work that specific B cells
selected by panning and placed in a two-phase culture
system differentiate to specific-antibody-producing
plasma cells. However, it was not possible to say if
the initial CD40/IL-4 phase actually induced expan-
sion of the selected B cells because too few cells were
available for a proliferation assay.
Prolonged Contact with Antigen Inhibits Specific
Antibody Production in CD40-Stimulated B Cells
The low frequency of antibody-producing cultures
leads us to ask whether the duration of contact with
antigen during or after panning might influence B-cell
responsiveness.
In order to test this, peripheral blood MNC from
two donors recently boosted for tetanus were placed
in tetanus-toxoid-coated plates and the specific B cells
were allowed to adhere following the procedure for
panning as described above. After removal of the
nonadherent cells by thorough washing, the irradiated
CD32/L cells, anti-CD40, and IL-4 were added to the
panning plates and allowed to incubate either over-
night or for 4 days. At the end of the initial 24-hour or
4-day culture period, the cells were removed, washed,
and transferred to freshly irradiated CD32/L cells
with anti-CD40 and IL-4 for a further 5 days. In each
case, the medium was refreshed and the cultures were
continued with IL-10/IL-2. Supernatant was harvested
at day 14, 17, and 21. Antigen-specific antibody was
detected when the panned B cells were washed to
remove antigen and transferred to fresh cultures after
1 day, but could not be detected in either donor when
the B-cell cultures were continued in the panning266 GRZEGORZ SKIBINSKI et al.
TABLE II Total IgM, IgG, and Tetanus-Specific B-Cell cultures Following or 4 Days Incubation with Antigen
No. positive wells at day 17
Transfer day Transfer day 4
Donor
Donor 2
IgM 3 4
IgG 4 4
TT 2 0
IgM 6 6
IgG 6 6
TT 3 0
aTetanus-specific B cells were selected and cultured in the presence of antigen for day or 4 days with CD32/L cells, anti-CD40, and IL-4
before washing and transferring to 24-well plates with anti-CD40/IL-4. After a further 5 days, the medium was refreshed and culture
continued with IL-2/IL- 10.
bTT tetanus toxoid.
plates for 4 days before removal of antigen (Table II).
This suggests that the continued presence of antigen
during culture inhibits the differentiation to plasma
cells in the specific B-cell population only since the
total IgM and IgG secretion was not affected. Also the
effect appears to be long lasting and could not be
reversed by the subsequent removal of antigen and
further culture with IL- 10/IL-2.
DISCUSSION
The most important finding from this study is that
prior selection of CMV-specific B cells enables the
detection of specific antibody in CD40-cultured B
cells that was not readily detectable in nonselected
polyclonal B cell cultures. We conclude that the
antigen-specific (CMV memory) B cells respond to
anti-CD40/cytokine-induced differentiation. An
important question that remains to be answered is
whether the lack of detection of specific antibody in
nonselected cultures is due to the extremely low
frequency of B memory cells or whether the antigen-
selection step (panning) gave an initial activation
signal that enabled subsequent response in the CD40
cultures. Furthermore, specific antibody was detected
generally only after 14 days using the present
protocol, suggesting, as indicated by others (Arpin et
al., 1995; Callard et al., 1995; Silvy et al., 1996), that
the continuing presence of anti-CD40 may delay
antibody production. Secondly, we found that the
continued presence of antigen, at least for the first 4
days of anti-CD40 culture, appeared to abolish the
specific antibody response from antigen-selected B
cells. This effect was long lasting and specific
antibody production could not be restored by sub-
sequent removal of antigen and continued culture
with IL- 10/IL-2 up to 21 days.
In the present study, our aim was to utilize the
proliferative properties of the combination anti-
CD40/IL-4 to obtain (clonal) expansion of the
selected B memory cells and then extended the
culture period to allow differentiation to antibody-
producing cells under the influence of IL-2/IL-10.
Several reports show that CD40 stimulation of B
memory cells (IgD-/CD38-) in vitro leads to pro-
liferation rather than differentiation to plasma cells
(Arpin et al., 1995; Callard et al., 1995; Silvy et al.,
1996) and that the differentiation of memory B cells
into antibody-secreting cells can be achieved on
costimulation with IL-2 and IL-10 without the
engagement of CD40. In the present study, we expect
a decreased effect of anti-CD40 after 14 days culture
and this may contribute to the increased detection of
antigen-specific antibody measured after this time.
A notable feature of these cultures was that the
degree of proliferation observed in peripheral blood
(antigen-selected) B cells appeared limited compared
to what we expected on the basis of comparable
cultures of (antigen-selected or -unselected) spleen B
cells. This reflects an important difference between
small circulating B cells that generally have a low
expression of the B-cell "preactivation" marker,
CD21, and the spleen B-cell population containingAG-SPECIFIC ANTIBODY IN THE CD40 SYSTEM 267
anywhere from 5-50% marginal-zone B cells that are
CD21 higr. Although blood and spleen (comprising
centrocytes, centroblasts, marginal zone, mantle zone,
and PB B cells) represent quite different B-cell
compartments, the results illustrate that enrichment
for antigen-specific B cells from both populations is
possible using this technique. In these preliminary
experiments, no attempt was made to characterize the
ability of the different B-cell subsets to respond in the
CD40 cultures.
The effect of different doses of antigen was
examined in the CD40/IL-4 cultures of the non-
selected B cells, but no effect on specific antibody
production was detected. It is likely that the effect of
varying antigen concentration is masked by the
continuing presence of anti-CD40 that inhibits anti-
body production. No attempt was made to vary
antigen concentration with B cells selected by pan-
ning since a certain degree of antigen coating on
plastic panning trays is inherent in the panning
technique. It should also be remembered that it is not
only the antigen concentration that may affect B cell
activation, but also the time of exposure to antigen, as
shown by the present results.
CD40 and IL-4 costimulation has been reported to
induce proliferation and prevent the apoptosis medi-
ated by hyper cross-linking of IgM+/IgD peripheral
B cells (Parry et al., 1994). A proliferation assay of
the antigen-specific B cells in the current experiments
was not performed due to the extremely low numbers
of specific B cells harvested after panning. In an
alternative system for expanding antigen-specific B
cells using an EL-4 thymoma line and T-cell culture
medium (Steenbakkers, 1994; Lagerkvist et al.,
1995), proliferation of the selected B cells is clearly
visible up to about day 10. However, this system
results in B cells lying free (personal observation) as
opposed to tight aggregates as observed in the CD40
culture system. Although EL-4 cells also ligate CD40
on B cells, the mixture of different cytokines in the T-
cell supernatant may explain the difference in
observed proliferation. The T-cell replacing factor
used with the EL-4 cultures is either a PWM-
stimulated T-cell supernatant (Lagerkvist et al., 1995)
or a PHA-stimulated T-cell-macrophage supernatant
(Steenbakkers, 1994), and the cytokines thus induced
are likely to resemble those present in the PWM-
stimulated MNC cultures yielding the anti-CMV
antibody described at the beginning of this report.
Also the cytokine and phorbol myristate acetate
(PMA) induced induction of gp39 on the EL-4 cells
may more closely resemble transient gp39 expressed
on T cells than the long-term triggering via the CD32-
bound monoclonal antibody in the CD40 system.
The second important finding in the present study is
that the presence of antigen during the first 4 days of
culture appeared to abolish the specific antibody
response from antigen-selected B cells. It is possible
that BCR ligation by antigen during panning for
specific B cells provides an important costimulation
together with anti-CD40, but that the continued
presence of antigen during stimulation with anti-
CD40 may render these cells unresponsive. A similar
phenomenon has been described in vivo where soluble
antigen administered during the germinal center
reaction can cause enhanced apoptosis of germinal
center B cells and reduce B memory cell formation
(Pulendran et al., 1995; Shokat and Goodnow, 1995).
Supporting this, Galibert et al. (1996b) have reported
that prolinged BCR cross-linking of CD40-activated
GC B cells can lead to negative selection of these
cells. Further experiments are necessary to determine
if the abolition of the specific antibody response
reported here is dependent on the concentration and
valency of the antigen. In the present study, the
antigen concentration was determined by the amount
of antigen bound to the panning plates after incuba-
tion of the antigen coating solution overnight.
It is interesting to compare the present findings
with those of Callard et al. (1995), who describe good
proliferation but inhibition of the specific antibody
(influenza) response after CD40 cross-linking of
highly purified tonsil B cells. There are a number of
important differences in their approach such as the
absence of CD32/L cells for cross-linking anti-CD40
and the use of a different anti-CD40 Mab. Most
significant, however, is the presence of antigen for the
first 6 days of culture with anti-CD40 and culture in
IL-2 instead of IL-2/IL-10, as described in the present
experiments. They conclude that it is the CD40 cross-268 GRZEGORZ SKIBINSKI et al.
linking that inhibits specific antibody production by
human B cells, but did not consider the fact that it
may be the long-term dual triggering of the BCR and
anti-CD40 that is having this effect. In addition,
whereas T cells have been found to activate B cells in
a CD40- and IL-2-dependent fashion (Blanchard et
al., 1994) and IL-2 was essential for the anti-influenza
antibody production by immunized MNC in vitro
(Callard et al., 1995), IL-2 alone appears unable to
activate B cells in the CD40 system (Blanchard et al.,
1994). This is in contrast to BCR stimulation by
antigen or SAC in the absence of anti-CD40. We and
others have found IL-2 to augment the specific
(Callard et al., 1995) or polyclonal antibody produc-
tion in BCR-triggered B cells in vitro (Jelenek and
Lipsky, 1988; Splawski et al., 1993; Itoh et al., 1994,
Schilizzi et al., 1997).
The inhibition of specific antibody production by
the continued presence of antigen may explain our
inability to selectively trigger antigen-specific B cells
by simultaneous stimulation with anti-CD40 and
CMV antigens in the absence of cytokines, because in
these experments, antigen was also continuously
present. Wheeler et al. (1993) have found that
engagement of CD40 lowers the threshold for activa-
tion of resting B cells via the antigen receptor when
the antigen receptor is triggered with IgG1 anti-/z
bound by its Fc region to CD32/L cells. However,
they did not report the effect of coligation of CD40
and BCR on antibody production in these experi-
ments.
In contrast to our results, Nonoyama et al. (1993)
have reported antigen-specific antibody produced in
vitro by CD40-triggered human B cells cultured for
12 days in the presence of antigen and IL-10. They
selected CD19+/IgD peripheral blood B cells from
volunteers recently immunized and boosted with the
phage + X174 and found that in vitro antigen
stimulation was essential and synergistic with anti-
CD40 and IL-10. The presumably high frequency of
the specific B cells in their system may explain this
discrepancy since in their experiments it was not
necessary to select the phage-specific B cells before
culture. Other factors determining B-cell responsive-
ness and that make it difficult to compare with our
antigen-stimulated cultures are the nature and concen-
tration of the antigen (Bachmann et al., 1993). Also,
direct comparison is not possible since we did not
perform any cultures where specific B cells or total B
cells were stimulated with anti-CD40, antigen, and
IL-10 as the only cytokine present.
It is not known whether naive cells preferentially
survive in culture following CD40 ligation and I1-4 or
whether it is a question of overgrowth of nonspecific
B cells that hinders detection of a specific antibody.
Furthermore, a complicating factor is that CD40
ligation initially stimulates proliferation and reduces
antibody production (Arpin et al., 1995, Schilizzi et
al., manuscript in preparation). So the question is
really whether naive B cells preferentially survive in
this system, whether they overgrow the memory B
cells, or whether the antibody production of the
memory B cells is being suppressed due to the
continuing presence of anti-CD40.
This study supports a model for B-cell activation
by T-dependent antigens in which CD40 ligand and
cytokines costimulate with BCR ligation and that
these signals are likely to be sequential and transient
in nature. In vivo, CD40-CD40 ligand contact is short-
lasting and tightly regulated by mechanisms such as
internalization ofCD40 ligand in T cells (Yellin et al.,
1994). Multiple-step culture experiments are needed
to unravel the key factors in the induction and
differentiation of B memory cells.
MATERIALS AND METHODS
Reagents
Purified rIL-4 and rIL-10 were obtained as gifts from
Schering-Plough Research (Kenilworth, NJ) and used
at 100 U/ml and 100 ng/ml, respectively. Purified
r.IL-2 (Cetus, Amsterdam) was used at 10 ng/ml and
anti-CD40 (Clone 89; Immunotech, France) was used
at a final concentration of 0.5 #g/ml. Mouse anti-
human CD20-FITC and mouse IgG1 anti-pp65 were
kindly provided by MCA Development b.v. (Gro-
ningen, The Netherlands).AG-SPECIFIC ANTIBODY IN THE CD40 SYSTEM 269
Cell Lines
Mouse Ltk- cells transfected with the gene for human
CD32 (CD32-L cells) were obtained from H. Kluin-
Nellemans (Department of Hematology, AZ Leiden),
with permission from J. Banchereau (Schering-
Plough, Dardilly, France). The cells were maintained
in the RPMI 1640 culture medium described below, to
which was added HT supplement (GIBCO 50x) and
0.1 mM aminopterin (GIBCO, Paisley, Scotland).
B-Cell Preparation
The B cells used in the present experiments were (a)
CD20 FACS-purified splenic B cells from one
subject, used as a total population or after panning the
CD20-positive population over antigen-coated plastic,
or (b) peripheral blood cells cultured either as
unfractionated mononuclear cell suspensions or as B
cells enriched by panning over antigen-coated plastic
plates. Spleen was obtained immediately postmortem
from individuals with no known illness or current
infection. Both spleen and PB cells were from CMV-
positive subjects. The different B-cell populations
studied are shown in Table 1.
Spleen Cells
Mononuclear cells were isolated from spleen, by
density-gradient centrifugation over Lymphoprep
(Nycomed, Oslo) and subsequently stored at 20
106/ml, at -80C. Aliquots of splenic MNC were
thawed as required, and any dead cells were removed
by centrifugation over Lymphoprep, washed twice in
RPMI 1640 medium (GIBCO), and labeled with anti-
CD20 FITC. B cells were obtained by FACS-STAR
(Becton-Dickinson, Mountainview, CA) single-cell
sorting to yield B-cell suspensions of greater than
98% purity. The cells were washed once and resus-
pended at 4 105/ml in a culture medium consisting
of RPMI 1640 supplemented with 60/zg/ml gentami-
cine, mM Na pyruvate, 2 mM glutamine, 0.05 mM
/3-ME, and 15% FCS (BioWhittaker, Verviers,
France). These cells were either placed directly in
CD40 cultures (see "B-Cell Cultures," below) or used
for panning similarly to monocyte-depleted blood-cell
suspensions (see "Panning," below).
Peripheral Blood
MNC from two tubes of heparinized peripheral blood
from patients with an active CMV infection were
isolated over lymphoprep. The cells were then
washed, resuspended to about 2 106/ml in culture
medium, and adherent cells were removed by incubat-
ing for 30 min at 37C in a 75-cm culture flask
placed horizontally. The nonadherent, MNC fraction
was used for panning over plastic-coated antigen to
select specific B cells or in MNC cultures, as
described in below.
Panning Specific B Cells for the CD40 System
The panning procedure was performed exactly as
described by Steenbakkers et al. (1994). The mono-
cyte-depleted PB-cell suspensions or CD20 purified
spleen B cells were then added to six-well culture
plates (Costar, Cambridge, MA) that had been coated
with antigen overnight at 4C. The antigen used was
either an extract of CMV LA (CMV late antgen)-
infected fetal lung fibroblasts or the recombinant
proteins pp65 and gH. The optimal concentration for
antigen coating was tested by ELISA using a human
mAb specific for pp65 (07b) or gH-reactive patient
serum. The detection of CMV LA, r.pp65, and gH in
this way showed that both the CMV-infected fibro-
blast extract and recombinant proteins used for
panning are in a form able to be recognized by B cells
bearing sIg specific for CMV.
After incubating the MNC or purified B cells in the
panning plates for 90 min at 37C and 5% CO2, the
unbound cells were removed and the wells were
washed six times with PBS. The bound B cells were
removed by trypsinization that was stopped with the
addition to each plate of a 5-ml culture medium
containing 10% FCS. The harvested cells were placed
in culture without further washing. The selected B
cells were resuspended in a 5-ml culture medium and
divided over 48 wells of a microtiter plate in which
irradiated CD32-L cells (2 104/well) had been270 GRZEGORZ SKIBINSKI et al.
placed. Anti-CD40 and cytokines were added as
described in what follows (see "CD40 System").
B-Cell Cultures: CD40 System
(a) For measurement of specific and total Ig produc-
tion, the FACS-sorted human splenic B cells were
seeded in triplicate or quadruplicate in 96-well culture
plates (Costar, Cambridge, MA.) at 4 104/well on
irradiated (80 GY) CD32-L cells (2 104/well). Anti-
CD40 (mAb89) and the cytokines IL-4 or IL-10 and
IL-2 were added as indicated in a final volume of 200
#1 per well. Antigen-selected (panned) B cells were
not counted but divided over 48 wells of the 96-well
culture plate and cultured as described above. Culture
medium was refreshed after 7 days by replacing 100
/1 of the medium and the addition of fresh cytokines.
The supernatant was generally harvested after 7 and
14 days for quantitation of secreted Ig. In some
experments, supernatant was also collected at days 17
and 21.
(b) For proliferation assays, CD32/L cells were
irradiated and seeded into 96-well round-bottom
tissue-culture plates (Costar). Human splenic B cells
(105/well) and various combinations of cytokines
were added as indicated in the following section.
[3H]-thymidine (sp.act. 2 Ci/mmol; Wilmington, DE)
was added for the last 16 hr (1 /zCi/well) of a 4-day
culture and incorporation was measured by liquid
scintillation counting.
Analysis of Antibody Responses
Culture supernatants were analyzed by ELISA for the
presence of total human IgM and IgG as well as
antibodies specific for the CMV antigens pp65, gH,
and CMV LA. In some experiments, anti-tetanus
antibodies were measured. The antigens used for
coating were (a) CMV LA (late antigens) prepared as
described (Middeldorp et al., 1984), (b) r.pp65
prepared as described by van Zanten et al. (1995), (c)
r.gH prepared similarly, or (d) tetanus toxoid (SVM,
Bilthoven, The Netherlands). The CMV-specific
ELISA was performed as described previously (van
der Giessen et al., 1990) with some slight modifica-
tions. Briefly, microtiter plates (Dynatech, Alexan-
dria, VA) were coated 48 hr with 1 /zg/ml of antigen
(CMV proteins or tetanus toxoid) or goat anti-human
IgM or IgG (Biosource, Camarillom, CA) in 50 mM
carbonate buffer, pH 9.6. Alkaline phosphatase conju-
gated goat anti-human IgM and goat anti-human IgG
(SBA, Birmingham, AL) were used separately or
combined as required, to detect bound antibodies. The
substrate used was Nitrophenyl phosphate disodium
(Sigma Chemical, St. Louis), dissolved in diethanola-
mine buffer 10%, pH 9.8. The CMV-specific mono-
clonal antibody (mab 07b) or CMV-positive patient
serum was used as a positive control in the CMV-
specific ELISA. The concentrations of IgM and IgG
in the supernatant were determined by comparison
with a standard curve using a standard human serum
(Behringwerke AG, Marburg, Germany).
MNC Cell Cultures: CD40 or PWM Controls
Specific and Total Ig Production by Peripheral
Blood MNC Cultures
MNC from healthy volunteers or patients with an
active CMV infection were isolated by density-
gradient centrifugation over Lymphoprep (Nycomed).
After washing twice in RPMI 1640, the MNC were
resuspended in RPMI culture medium and seeded at 2
105/well in 96-well round-bottom plates (Costar) in
the presence of PWM or anti-CD40 and CD32-L
cells.
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